Edging closer to early optimal patient management with high-sensitivity cardiac troponin assay

Circulation

Volumn 124, Issue 2, 2011, Pages 127-129

  Apple, Fred S ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

acute coronary syndrome; acute myocardial infarction; biomarkers; Editorials

Indexed keywords

TROPONIN I;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADVERSE OUTCOME; ANALYTICAL EQUIPMENT; CELL DEATH; DIAGNOSTIC ACCURACY; EDITORIAL; HEART DISEASE; HEART MUSCLE CELL; HUMAN; LUNG EMBOLISM; MAJOR ADVERSE CARDIAC EVENT; MYOCARDITIS; OUTCOME ASSESSMENT; PATIENT CARE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SEPSIS;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TROPONIN I; TROPONIN T;

EID: 79960385473     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.038851     Document Type: Editorial

References (16)

1. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, Wu AHB, Christenson RH, Apple FS, Francis G, Tang W. National Academy of Clinical Biochemistry practice guidelines: clinical characteristics and utilization of biomarkers in acute coronary syndromes. Clin Chem. 2007;53:552-574. (Pubitemid 46580223)
2. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underswood R, Bax JJ, Beller GA, Bonow R, Van Der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernandez-Aviles F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM; on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007;50:2173-2195. (Pubitemid 350123680)
3. Gibler WB, Canon CP, Blomkains AL, Char DM, Drew BJ, Hollander JE, Jaffe A, Jesse R, Newby LK, Ohman EM, Peterson ED, Pollack CV. Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department. Ann Emerg Med. 2005;46:185-197. (Pubitemid 41039018)
4. Wilson SR, Sabatine MS, Braunwald E, Sloan S, Murphy SA, Morrow DA. Detection of myocardial injury in patients with unstable angina using nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 trial. Am Heart J. 2009;158:386-391.
5. Lindahl B, Venge P, James S. The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes. Am Heart J. 2010;160:224-229
6. deFillipi C, de Lemos J, Christenson R, Gotttdiener J, Kop W, Zhan M, Seliger S. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA. 2010;304:2494-2502.
7. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA, McGuire DK. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 2010; 304:2503-2512.
8. Jaffe A, Apple FS, Morrow D, Lindahl B, Katus H. Being rational about (Im)precision: a statement from the biochemistry subcommittee of the joint ESC-ACCF-AHA-WHF Task Force for the Definition of Myo-cardial Infarction. Clin Chem. 2010;56:941-943.
9. Reichlin T, Irfan A, Twerenbold R, Reiter M, Hochholzer W, Crettol H, Bassetti S, Steuer S, Winkler K, Peter F, Meissner J, Haaf P, Potocki M, Drexler B, Osswald S, Mueller C. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myo-cardial infarction. Circulation. 2011;124:136-145.
10. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S, Schaub N, Buerge C, Potocki M, Noveanu M, Breidthardt T, Twerenbold R, Winkler K, Bingisser R, Mueller C. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361:858-867.
11. Apple FS. Opinion: a new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem. 2009;55:1303-1306.
12. Wallace T, Abdulah S, Drazner M, Das S, Khera A, McGire D, Wians F, Sabatine M, Morrow D, de Lemos J. Prevalence and determinants of troponin T elevation in the general population. Circulation. 2006;113: 1958-1965.
13. Alcalai R, Planer D, Culhaoglu A, Osman A, Pollak A, Lotan C. Acute coronary syndrome vs nonspecific troponin elevation: clinical predictors and survival analysis. Arch Intern Med. 2007;167:276-281.
14. Wu AH, Lu QA, Todd J, Moecks J, Wians F. Short-and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem. 20089; 55:52-58.
15. Vasile V, Saenger AK, Kroning JM, Jaffe AS. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56:1086-1090.
16. Apple FS, Pearce LA, Smith SW, Kaczmarek JM, Murakami MM. Use of VITROS Troponin I ES assay for early diagnosis of myocardial infarction and predicting of adverse events: role of following deltas. Clin Chem. 2009;55:930-938.